Long-term effects of the COVID-19 pandemic on five mental and psychological disorders: in terms of the number of disease visits, drug consumption, and scale scores.

Publication date: Sep 18, 2023

COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou. We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done. From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P

Open Access PDF

Concepts	Keywords
December	Epidemiology
Pandemic	Long-term effects
Psychiatry	The COVID-19 pandemic
Wenzhou

Semantics

Type	Source	Name
disease	MESH	COVID-19 pandemic
disease	MESH	infections
pathway	REACTOME	Reproduction
drug	DRUGBANK	Guanosine
drug	DRUGBANK	Coenzyme M
disease	MESH	dementia praecox
disease	MESH	psychiatric disorders
disease	MESH	viral encephalitis
disease	IDO	infection
disease	MESH	psychosis
disease	MESH	bipolar disorder
disease	VO	organization
disease	VO	population
disease	MESH	sleep disorders
disease	MESH	chronic diseases
disease	VO	time
drug	DRUGBANK	Serotonin
drug	DRUGBANK	Norepinephrine
drug	DRUGBANK	Dopamine
drug	DRUGBANK	Tandospirone
disease	VO	effective
disease	MESH	depressive disorder
drug	DRUGBANK	Mirtazapine
disease	MESH	loneliness
disease	MESH	insomnia
disease	MESH	paranoia
disease	MESH	suicide
disease	MESH	shock
disease	MESH	lifestyle
disease	MESH	suicidal ideation
disease	MESH	eating disorders
disease	MESH	excessive daytime sleepiness
disease	MESH	post traumatic stress disorder
disease	IDO	country
drug	DRUGBANK	Etoperidone
disease	MESH	uncertainty
disease	IDO	symptom
disease	MESH	anorexia nervosa
drug	DRUGBANK	Trestolone
disease	MESH	functional gastrointestinal disorders
disease	MESH	anxiety Disorders
pathway	KEGG	Circadian rhythm
disease	MESH	Substance Use
disease	VO	age

Original Article

(Visited 1 times, 1 visits today)